AAAAAA

   
Results: 1-10 |
Results: 10
Phosphate prodrugs of PD154075
Authors: Zhu, ZJ Chen, HG Goel, OP Chan, OH Stilgenbauer, LA Stewart, BH
Citation: Zj. Zhu et al., Phosphate prodrugs of PD154075, BIOORG MED, 10(10), 2000, pp. 1121-1124
Oral delivery of HIV-protease inhibitors
Authors: Li, LY Stewart, BH Fleisher, D
Citation: Ly. Li et al., Oral delivery of HIV-protease inhibitors, CR R THER, 17(2), 2000, pp. 73-99
Atorvastatin transport in the Caco-2 cell model: Contributions of P-glycoprotein and the proton-monocarboxylic acid co-transporter
Authors: Wu, XC Whitfield, LR Stewart, BH
Citation: Xc. Wu et al., Atorvastatin transport in the Caco-2 cell model: Contributions of P-glycoprotein and the proton-monocarboxylic acid co-transporter, PHARM RES, 17(2), 2000, pp. 209-215
Atorvastatin coadministration may increase digoxin concentrations by inhibition of intestinal P-glycoprotein-mediated secretion
Authors: Boyd, RA Stern, RH Stewart, BH Wu, XC Reyner, EL Zegarac, EA Randinitis, EJ Whitfield, L
Citation: Ra. Boyd et al., Atorvastatin coadministration may increase digoxin concentrations by inhibition of intestinal P-glycoprotein-mediated secretion, J CLIN PHAR, 40(1), 2000, pp. 91-98
Ex vivo approaches to predicting oral pharmacokinetics in humans
Authors: Stewart, BH Wang, Y Surendran, N
Citation: Bh. Stewart et al., Ex vivo approaches to predicting oral pharmacokinetics in humans, ANNU REP M, 35, 2000, pp. 299-307
Transport of pregabalin in rat intestine and Caco-2 monolayers
Authors: Jezyk, N Li, C Stewart, BH Wu, XC Bockbrader, HN Fleisher, D
Citation: N. Jezyk et al., Transport of pregabalin in rat intestine and Caco-2 monolayers, PHARM RES, 16(4), 1999, pp. 519-526
Evidence for overlapping substrate specificity between large neutral aminoacid (LNAA) and dipeptide (hPEPT1) transporters for PD 158473, an NMDA antagonist
Authors: Surendran, N Covitz, KMY Han, HK Sadee, W Oh, DM Amidon, GL Williamson, RM Bigge, CF Stewart, BH
Citation: N. Surendran et al., Evidence for overlapping substrate specificity between large neutral aminoacid (LNAA) and dipeptide (hPEPT1) transporters for PD 158473, an NMDA antagonist, PHARM RES, 16(3), 1999, pp. 391-395
CHO/hPEPT1 cells overexpressing the human peptide transporter (hPEPT1) as an alternative in vitro model for peptidomimetic drugs
Authors: Han, HK Rhie, JK Oh, DM Saito, G Hsu, CP Stewart, BH Amidon, GL
Citation: Hk. Han et al., CHO/hPEPT1 cells overexpressing the human peptide transporter (hPEPT1) as an alternative in vitro model for peptidomimetic drugs, J PHARM SCI, 88(3), 1999, pp. 347-350
Hydrophobicity of HIV protease inhibitor by immobilized artificial membrane chromatography: Application and significance to drug transport (vol 15, pg 1401, 1998)
Authors: Stewart, BH Chung, FY Tait, B Blankley, CJ Chan, OH
Citation: Bh. Stewart et al., Hydrophobicity of HIV protease inhibitor by immobilized artificial membrane chromatography: Application and significance to drug transport (vol 15, pg 1401, 1998), PHARM RES, 15(12), 1998, pp. 1911-1911
Use of immobilized artificial membrane chromatography for drug transport applications
Authors: Stewart, BH Chan, OH
Citation: Bh. Stewart et Oh. Chan, Use of immobilized artificial membrane chromatography for drug transport applications, J PHARM SCI, 87(12), 1998, pp. 1471-1478
Risultati: 1-10 |